Breaking News Instant updates and real-time market news.

OXY

Occidental Petroleum

$25.55 /

+1.27 (+5.23%)

08:21
04/15/21
04/15
08:21
04/15/21
08:21

Scotiabank downgrades Occidental to Sector Perform amid sector rating shake-up

As previously reported, Scotiabank analyst Paul Cheng downgraded Occidental Petroleum to Sector Perform from Outperform with a price target of $28, up from $26 , as he updated ratings and price targets across his coverage to account for his updated earnings models and commodity price deck. The stock has been among the best outperformers within the large cap E&P space since late October and he thinks the risk/reward no longer justifies an Outperform rating, said Cheng, who also sees limited near-term catalysts.

  • 07

    May

  • 11

    May

OXY Occidental Petroleum
$25.55 /

+1.27 (+5.23%)

04/15/21 Scotiabank
Occidental Petroleum downgraded to Sector Perform from Outperform at Scotiabank
04/14/21 MKM Partners
Occidental Petroleum upgraded to Buy at MKM Partners on valuation
04/14/21 MKM Partners
Occidental Petroleum upgraded to Buy from Neutral at MKM Partners
04/01/21 Piper Sandler
Occidental Petroleum price target raised to $30 from $21 at Piper Sandler

TODAY'S FREE FLY STORIES

Hot Stocks
FDA approves Merck's KEYTRUDA for adjuvant treatment of stage IIB, IIC melanoma » 18:17
12/03/21
12/03
18:17
12/03/21
18:17
MRK

Merck

$73.32 /

-0.57 (-0.77%)

Merck announced that the…

Merck announced that the U.S. Food and Drug Administration has approved KEYTRUDA, Merck's anti-PD-1 therapy, for the adjuvant treatment of adult and pediatric patients with stage IIB or IIC melanoma following complete resection. Additionally, the FDA expanded the indication for KEYTRUDA as adjuvant treatment for stage III melanoma following complete resection to include pediatric patients. The approval in stage IIB and IIC melanoma is based on data from the first interim analysis of the Phase 3 KEYNOTE-716 trial, in which KEYTRUDA showed a statistically significant improvement in recurrence-free survival (RFS), reducing the risk of disease recurrence or death by 35% compared to placebo. Median RFS was not reached for either group. After a median follow-up of 14.4 months, 11% of patients who received KEYTRUDA had recurrence or died compared to 17% of patients who received placebo. Efficacy in pediatric patients with stage IIB, IIC and III melanoma is supported by extrapolation of efficacy data from adults, given similar biology, pharmacology of drug effect, as well as similar exposure-response for efficacy and safety.

ShowHide Related Items >><<
MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

Hot Stocks
Pure Storage director Tomb sells 29,311 class A shares » 18:12
12/03/21
12/03
18:12
12/03/21
18:12
PSTG

Pure Storage

$31.61 /

-0.03 (-0.09%)

In a regulatory filing,…

In a regulatory filing, Pure Storage director Gregory Tomb disclosed the sale of 29,311 class A common shares of the company on December 2 at a price of $31.4456 per share.

ShowHide Related Items >><<
PSTG Pure Storage
$31.61 /

-0.03 (-0.09%)

PSTG Pure Storage
$31.61 /

-0.03 (-0.09%)

12/01/21 Susquehanna
Pure Storage price target raised to $36 from $33 at Susquehanna
11/24/21 Wedbush
Pure Storage price target raised to $33 from $25 at Wedbush
11/24/21 Lake Street
Pure Storage price target raised to $34 from $31 at Lake Street
11/24/21 Northland
Pure Storage price target raised to $40 from $36 at Northland
PSTG Pure Storage
$31.61 /

-0.03 (-0.09%)

PSTG Pure Storage
$31.61 /

-0.03 (-0.09%)

PSTG Pure Storage
$31.61 /

-0.03 (-0.09%)

Periodicals
UniCredit's German arm to take large portion of layoffs, Reuters reports » 18:04
12/03/21
12/03
18:04
12/03/21
18:04
UNCRY

UniCredit

$6.23 /

-0.02 (-0.32%)

UniCredit's German…

UniCredit's German business is poised to take a significant portion of the roughly 3,000 job cuts anticipated under the bank's new business plan, Reuters' Valentina Za reports, citing person close to the matter. The company will unveil a new business plan on December 9, Za says. Reference Link

ShowHide Related Items >><<
UNCRY UniCredit
$6.23 /

-0.02 (-0.32%)

UNCRY UniCredit
$6.23 /

-0.02 (-0.32%)

11/25/21 Goldman Sachs
UniCredit reinstated with a Conviction Buy at Goldman Sachs
11/09/21 HSBC
UniCredit upgraded to Buy from Hold at HSBC
11/02/21 UBS
UniCredit price target raised to EUR 14.65 from EUR 14.45 at UBS
10/26/21 Societe Generale
UniCredit price target raised to EUR 12 from EUR 10.60 at Societe Generale
UNCRY UniCredit
$6.23 /

-0.02 (-0.32%)

UNCRY UniCredit
$6.23 /

-0.02 (-0.32%)

Hot Stocks
LGI Homes reports 797 home closings in November » 17:56
12/03/21
12/03
17:56
12/03/21
17:56
LGIH

LGI Homes

$151.70 /

-2.085 (-1.36%)

LGI Homes announced it…

LGI Homes announced it closed 797 homes in November 2021. The company ended the first eleven months of 2021 with 9,438 home closings, a 22.4% increase over 7,709 home closings during the first eleven months of 2020. As of November 30, 2021, the company had 104 active selling communities.

ShowHide Related Items >><<
LGIH LGI Homes
$151.70 /

-2.085 (-1.36%)

LGIH LGI Homes
$151.70 /

-2.085 (-1.36%)

10/14/21 JPMorgan
LGI Homes price target lowered to $115 from $156 at JPMorgan
06/18/21 JMP Securities
LGI Homes price target raised to $175 from $140 at JMP Securities
05/06/21 Wells Fargo
LGI Homes price target raised to $175 from $150 at Wells Fargo
05/05/21 Wedbush
LGI Homes price target raised to $155 from $135 at Wedbush
LGIH LGI Homes
$151.70 /

-2.085 (-1.36%)

Periodicals
India withdraws patent for PepsiCo's Lay's potato variety, Reuters reports » 17:55
12/03/21
12/03
17:55
12/03/21
17:55
PEP

PepsiCo

$164.69 /

+4.06 (+2.53%)

India's Protection…

India's Protection of Plant Varieties and Farmers' Rights Authority issued an order revoking a patent for a potato variety grown exclusively for PepsiCo's Lay's potato chip products, Reuters' Sumit Khanna and Mayank Bhardwaj report. In 2019, the company sued some farmers in India's Gujarat for cultivating the FC5 potato variety, which has a lower moisture content needed to make salty snacks, the authors say, noting that PepsiCo withdrew the suits that same year in an attempt to settle the issue amicably. The PPVFR Authority, however, agreed with a farmers rights' activist's contention that the beverage and snack giant cannot claim a patent over a seed variety, the authors note. Reference Link

ShowHide Related Items >><<
PEP PepsiCo
$164.69 /

+4.06 (+2.53%)

PEP PepsiCo
$164.69 /

+4.06 (+2.53%)

10/07/21 Barclays
PepsiCo price target raised to $168 from $165 at Barclays
10/06/21 UBS
PepsiCo price target raised to $172 from $170 at UBS
10/06/21 Argus
PepsiCo reported 'strong quarter', says Argus
10/06/21 Deutsche Bank
PepsiCo price target raised to $160 from $158 at Deutsche Bank
PEP PepsiCo
$164.69 /

+4.06 (+2.53%)

PEP PepsiCo
$164.69 /

+4.06 (+2.53%)

PEP PepsiCo
$164.69 /

+4.06 (+2.53%)

PEP PepsiCo
$164.69 /

+4.06 (+2.53%)

Hot Stocks
BOK Financial CFO Nell sells 8,000 common shares » 17:49
12/03/21
12/03
17:49
12/03/21
17:49
BOKF

BOK Financial

$103.87 /

-1.77 (-1.68%)

In a regulatory filing,…

In a regulatory filing, BOK Financial CFO Steven Nell disclosed the sale of 8,000 common shares of the company on December 2 at a price of $106.1252 per share.

ShowHide Related Items >><<
BOKF BOK Financial
$103.87 /

-1.77 (-1.68%)

BOKF BOK Financial
$103.87 /

-1.77 (-1.68%)

10/25/21 Wedbush
BOK Financial price target raised to $102 from $96 at Wedbush
10/21/21 RBC Capital
BOK Financial price target raised to $101 from $94 at RBC Capital
03/08/21 Truist
BOK Financial price target raised to $93 from $82 at Truist
01/22/21 Truist
BOK Financial price target raised to $82 from $75 at Truist
BOKF BOK Financial
$103.87 /

-1.77 (-1.68%)

Hot Stocks
SolarEdge jumps 2.6% to $315.10 after being included in S&P500 effective 12/20  17:44
12/03/21
12/03
17:44
12/03/21
17:44
SEDG

SolarEdge

$306.25 /

-11.29 (-3.56%)

 
ShowHide Related Items >><<
SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

11/30/21
Fly Intel: Top five analyst downgrades
11/30/21 Morgan Stanley
SolarEdge downgraded to Equal Weight from Overweight at Morgan Stanley
11/22/21 Wells Fargo
SolarEdge initiated with an Overweight at Wells Fargo
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

Hot Stocks
Asana CEO buys $25M in common stock » 17:43
12/03/21
12/03
17:43
12/03/21
17:43
ASAN

Asana

$67.01 /

-24.155 (-26.50%)

In a regulatory filing,…

In a regulatory filing, Asana disclosed that its CEO Dustin Moskovitz bought 250K shares of common stock on December 1st in a total transaction size of $25.0M, boosting his stake by about 3%.

ShowHide Related Items >><<
ASAN Asana
$67.01 /

-24.155 (-26.50%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

12/03/21 JMP Securities
Asana price target raised to $95 from $85 at JMP Securities
11/18/21 Piper Sandler
Asana price target raised to $140 from $85 at Piper Sandler
11/04/21 Jefferies
Asana downgraded to Hold from Buy at Jefferies
10/21/21 KeyBanc
Asana price target raised to $143 from $85 at KeyBanc
ASAN Asana
$67.01 /

-24.155 (-26.50%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

Hot Stocks
Signature Bank, SolarEdge named to join the S&P 500 on December 20 » 17:40
12/03/21
12/03
17:40
12/03/21
17:40
SBNY

Signature Bank

$306.21 /

-13.78 (-4.31%)

, SEDG

SolarEdge

$306.25 /

-11.29 (-3.56%)

, FDS

FactSet

$466.62 /

-3.84 (-0.82%)

, LEG

Leggett & Platt

$41.72 /

-0.26 (-0.62%)

, HBI

Hanesbrands

$16.48 /

+0.03 (+0.18%)

, WU

Western Union

$17.23 /

+0.08 (+0.47%)

, M

Macy's

$26.80 /

-0.905 (-3.27%)

, VICR

Vicor

$137.46 /

-3.57 (-2.53%)

, POWI

Power Integrations

$97.91 /

-0.91 (-0.92%)

, TR

Tootsie Roll

$32.76 /

+0.235 (+0.72%)

, TDS

Telephone and Data

$18.12 /

+0.345 (+1.94%)

, NKTR

Nektar

$10.82 /

-0.58 (-5.09%)

S&P Dow Jones Indices…

S&P Dow Jones Indices will make several index changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 to ensure each index is more representative of its market capitalization range. The changes will be effective prior to the open of trading on Monday, December 20, 2021 to coincide with the quarterly rebalance: S&P MidCap 400 constituents Signature Bank (SBNY), SolarEdge Technologies Inc. (SEDG) and FactSet Research Systems Inc. (FDS) will move to the S&P 500, replacing S&P 500 constituents Leggett & Platt Inc. (LEG), Hanesbrands Inc. (HBI) and The Western Union Co. (WU), all of which will move to the S&P MidCap 400. S&P SmallCap 600 constituents Macy's Inc. (M), Vicor Corp. (VICR) and Power Integrations Inc. (POWI) will move to the S&P MidCap 400, replacing S&P MidCap 400 constituents Tootsie Roll Industries Inc. (TR), Telephone and Data Systems Inc. (TDS), and Nektar Therapeutics (NKTR), all of which will move to the S&P SmallCap 600.

ShowHide Related Items >><<
WU Western Union
$17.23 /

+0.08 (+0.47%)

VICR Vicor
$137.46 /

-3.57 (-2.53%)

TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

SBNY Signature Bank
$306.21 /

-13.78 (-4.31%)

POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

M Macy's
$26.80 /

-0.905 (-3.27%)

LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

FDS FactSet
$466.62 /

-3.84 (-0.82%)

SBNY Signature Bank
$306.21 /

-13.78 (-4.31%)

11/15/21 Raymond James
Signature Bank price target raised to $400 from $360 at Raymond James
11/12/21 Stephens
ConnectOne Bancorp named a Best Idea at Stephens
10/21/21 UBS
Signature Bank price target raised to $375 from $288 at UBS
10/20/21 Wedbush
Signature Bank price target raised to $340 from $320 at Wedbush
SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

11/30/21
Fly Intel: Top five analyst downgrades
11/30/21 Morgan Stanley
SolarEdge downgraded to Equal Weight from Overweight at Morgan Stanley
11/22/21 Wells Fargo
SolarEdge initiated with an Overweight at Wells Fargo
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
FDS FactSet
$466.62 /

-3.84 (-0.82%)

12/01/21 RBC Capital
FactSet price target raised to $525 from $453 at RBC Capital
10/07/21 RBC Capital
FactSet price target raised to $453 from $425 at RBC Capital
09/30/21 Stifel
FactSet price target raised to $400 from $337 at Stifel
09/30/21
Fly Intel: Top five analyst upgrades
LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

02/10/21 Raymond James
Leggett & Platt downgraded to Outperform from Strong Buy at Raymond James
02/10/21 Raymond James
Leggett & Platt downgraded to Outperform from Strong Buy at Raymond James
HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

11/17/21 UBS
Hanesbrands price target lowered to $20 from $23 at UBS
10/04/21 Wedbush
Wedbush sees several key tailwinds for footwear and apparel sector
10/04/21 Wedbush
Hanesbrands initiated with a Neutral at Wedbush
08/06/21 B. Riley
Hanesbrands price target raised to $24 from $22 at B. Riley
WU Western Union
$17.23 /

+0.08 (+0.47%)

11/03/21 Deutsche Bank
Western Union price target lowered to $18 from $25 at Deutsche Bank
10/20/21
Fly Intel: Top five analyst downgrades
10/20/21 BTIG
Western Union downgraded to Neutral from Buy at BTIG
10/14/21 Susquehanna
Western Union price target lowered to $23 from $26 at Susquehanna
M Macy's
$26.80 /

-0.905 (-3.27%)

11/19/21 Credit Suisse
Macy's price target raised to $32 from $19 at Credit Suisse
11/19/21 Deutsche Bank
Macy's price target raised to $35 from $29 at Deutsche Bank
11/19/21 Citi
Macy's price target raised to $29 from $20 at Citi
11/18/21 Gordon Haskett
Macy's price target raised to $50 from $37 at Gordon Haskett
VICR Vicor
$137.46 /

-3.57 (-2.53%)

10/22/21 Craig-Hallum
Craig-Hallum would be buyers of Vicor on any weakness following Q3 report
10/04/21 Craig-Hallum
Vicor price target raised to $200 from $150 at Craig-Hallum
04/23/21 Craig-Hallum
Vicor price target raised to $120 from $110 at Craig-Hallum
02/26/21 BWS Financial
Vicor price target raised to $120 from $100 at BWS Financial
POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

08/26/21 Benchmark
Power Integrations price target raised to $130 from $115 at Benchmark
08/19/21
Fly Intel: Top five analyst initiations
08/19/21 Benchmark
Power Integrations initiated with a Buy at Benchmark
07/30/21 Northland
Power Integrations upgraded to Outperform from Market Perform at Northland
TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

08/02/21
Fly Intel: Top five analyst downgrades
08/02/21 JPMorgan
JPMorgan downgrades Telephone and Data to sell on rising competition
08/02/21 JPMorgan
JPMorgan downgrades U.S. Cellular to sell, sees low likelihood of sale
08/02/21 JPMorgan
Telephone and Data downgraded to Underweight from Neutral at JPMorgan
NKTR Nektar
$10.82 /

-0.58 (-5.09%)

11/08/21 BTIG
Nektar price target lowered to $54 from $80 at BTIG
11/08/21 Benchmark
Nektar upgraded to Buy from Hold at Benchmark
11/05/21 Stifel
Stifel trims Nektar target but keeps Buy rating into melanoma data
09/10/21 BofA
Nektar initiated with a Neutral at BofA
WU Western Union
$17.23 /

+0.08 (+0.47%)

VICR Vicor
$137.46 /

-3.57 (-2.53%)

TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

SBNY Signature Bank
$306.21 /

-13.78 (-4.31%)

POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

M Macy's
$26.80 /

-0.905 (-3.27%)

LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

FDS FactSet
$466.62 /

-3.84 (-0.82%)

  • 21
    Jul
  • 05
    Feb
WU Western Union
$17.23 /

+0.08 (+0.47%)

M Macy's
$26.80 /

-0.905 (-3.27%)

WU Western Union
$17.23 /

+0.08 (+0.47%)

VICR Vicor
$137.46 /

-3.57 (-2.53%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

SBNY Signature Bank
$306.21 /

-13.78 (-4.31%)

POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

M Macy's
$26.80 /

-0.905 (-3.27%)

LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

FDS FactSet
$466.62 /

-3.84 (-0.82%)

WU Western Union
$17.23 /

+0.08 (+0.47%)

TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

M Macy's
$26.80 /

-0.905 (-3.27%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

Syndicate
AVCtechnologies files to sell 6.67M shares of common stock for holders  17:38
12/03/21
12/03
17:38
12/03/21
17:38
AVCT

AVCtechnologies

/

+

 
ShowHide Related Items >><<
AVCT AVCtechnologies
/

+

AVCT AVCtechnologies
/

+

04/14/21 Loop Capital
AVCtechnologies initiated with a Buy at Loop Capital
04/14/21 Loop Capital
AVCtechnologies initiated with a Buy at Loop Capital
04/08/21 Northland
Ribbon could see 'healthy return' on Kandy if AVC sold, says Northland
AVCT AVCtechnologies
/

+

AVCT AVCtechnologies
/

+

Hot Stocks
Power Integrations to replace Nektar in S&P MidCap 400 on 12/20  17:37
12/03/21
12/03
17:37
12/03/21
17:37
POWI

Power Integrations

$97.91 /

-0.91 (-0.92%)

, NKTR

Nektar

$10.82 /

-0.58 (-5.09%)

 
ShowHide Related Items >><<
POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

08/26/21 Benchmark
Power Integrations price target raised to $130 from $115 at Benchmark
08/19/21
Fly Intel: Top five analyst initiations
08/19/21 Benchmark
Power Integrations initiated with a Buy at Benchmark
07/30/21 Northland
Power Integrations upgraded to Outperform from Market Perform at Northland
NKTR Nektar
$10.82 /

-0.58 (-5.09%)

11/08/21 BTIG
Nektar price target lowered to $54 from $80 at BTIG
11/08/21 Benchmark
Nektar upgraded to Buy from Hold at Benchmark
11/05/21 Stifel
Stifel trims Nektar target but keeps Buy rating into melanoma data
09/10/21 BofA
Nektar initiated with a Neutral at BofA
POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

Hot Stocks
Nektar Therapeutics to replace Power Integrations in S&P SmallCap 600 on 12/20  17:34
12/03/21
12/03
17:34
12/03/21
17:34
NKTR

Nektar

$10.82 /

-0.58 (-5.09%)

, POWI

Power Integrations

$97.91 /

-0.91 (-0.92%)

 
ShowHide Related Items >><<
POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

11/08/21 BTIG
Nektar price target lowered to $54 from $80 at BTIG
11/08/21 Benchmark
Nektar upgraded to Buy from Hold at Benchmark
11/05/21 Stifel
Stifel trims Nektar target but keeps Buy rating into melanoma data
09/10/21 BofA
Nektar initiated with a Neutral at BofA
POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

08/26/21 Benchmark
Power Integrations price target raised to $130 from $115 at Benchmark
08/19/21
Fly Intel: Top five analyst initiations
08/19/21 Benchmark
Power Integrations initiated with a Buy at Benchmark
07/30/21 Northland
Power Integrations upgraded to Outperform from Market Perform at Northland
POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

POWI Power Integrations
$97.91 /

-0.91 (-0.92%)

NKTR Nektar
$10.82 /

-0.58 (-5.09%)

Hot Stocks
Telephone & Data Systems to replace Vicor in S&P SmallCap 600 on 12/20  17:34
12/03/21
12/03
17:34
12/03/21
17:34
TDS

Telephone and Data

$18.12 /

+0.345 (+1.94%)

, VICR

Vicor

$137.46 /

-3.57 (-2.53%)

 
ShowHide Related Items >><<
TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

08/02/21
Fly Intel: Top five analyst downgrades
08/02/21 JPMorgan
JPMorgan downgrades Telephone and Data to sell on rising competition
08/02/21 JPMorgan
JPMorgan downgrades U.S. Cellular to sell, sees low likelihood of sale
08/02/21 JPMorgan
Telephone and Data downgraded to Underweight from Neutral at JPMorgan
VICR Vicor
$137.46 /

-3.57 (-2.53%)

10/22/21 Craig-Hallum
Craig-Hallum would be buyers of Vicor on any weakness following Q3 report
10/04/21 Craig-Hallum
Vicor price target raised to $200 from $150 at Craig-Hallum
04/23/21 Craig-Hallum
Vicor price target raised to $120 from $110 at Craig-Hallum
02/26/21 BWS Financial
Vicor price target raised to $120 from $100 at BWS Financial
VICR Vicor
$137.46 /

-3.57 (-2.53%)

TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

VICR Vicor
$137.46 /

-3.57 (-2.53%)

Hot Stocks
Tootsie Roll to replace Macy's in S&P SmallCap 600 on 12/20  17:33
12/03/21
12/03
17:33
12/03/21
17:33
TR

Tootsie Roll

$32.76 /

+0.235 (+0.72%)

, M

Macy's

$26.80 /

-0.905 (-3.27%)

 
ShowHide Related Items >><<
TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

M Macy's
$26.80 /

-0.905 (-3.27%)

TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

M Macy's
$26.80 /

-0.905 (-3.27%)

11/19/21 Credit Suisse
Macy's price target raised to $32 from $19 at Credit Suisse
11/19/21 Deutsche Bank
Macy's price target raised to $35 from $29 at Deutsche Bank
11/19/21 Citi
Macy's price target raised to $29 from $20 at Citi
11/18/21 Gordon Haskett
Macy's price target raised to $50 from $37 at Gordon Haskett
TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

M Macy's
$26.80 /

-0.905 (-3.27%)

M Macy's
$26.80 /

-0.905 (-3.27%)

M Macy's
$26.80 /

-0.905 (-3.27%)

TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

M Macy's
$26.80 /

-0.905 (-3.27%)

Hot Stocks
Vicor to replace Telephone and Data Systems on S&P400 on 12/20  17:33
12/03/21
12/03
17:33
12/03/21
17:33
VICR

Vicor

$137.46 /

-3.57 (-2.53%)

, TDS

Telephone and Data

$18.12 /

+0.345 (+1.94%)

 
ShowHide Related Items >><<
TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

VICR Vicor
$137.46 /

-3.57 (-2.53%)

10/22/21 Craig-Hallum
Craig-Hallum would be buyers of Vicor on any weakness following Q3 report
10/04/21 Craig-Hallum
Vicor price target raised to $200 from $150 at Craig-Hallum
04/23/21 Craig-Hallum
Vicor price target raised to $120 from $110 at Craig-Hallum
02/26/21 BWS Financial
Vicor price target raised to $120 from $100 at BWS Financial
TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

08/02/21
Fly Intel: Top five analyst downgrades
08/02/21 JPMorgan
JPMorgan downgrades Telephone and Data to sell on rising competition
08/02/21 JPMorgan
JPMorgan downgrades U.S. Cellular to sell, sees low likelihood of sale
08/02/21 JPMorgan
Telephone and Data downgraded to Underweight from Neutral at JPMorgan
VICR Vicor
$137.46 /

-3.57 (-2.53%)

TDS Telephone and Data
$18.12 /

+0.345 (+1.94%)

VICR Vicor
$137.46 /

-3.57 (-2.53%)

Hot Stocks
Macy's to replace Tootsie Roll Industries in S&P400 on 12/20  17:32
12/03/21
12/03
17:32
12/03/21
17:32
M

Macy's

$26.80 /

-0.905 (-3.27%)

, TR

Tootsie Roll

$32.76 /

+0.235 (+0.72%)

 
ShowHide Related Items >><<
M Macy's
$26.80 /

-0.905 (-3.27%)

M Macy's
$26.80 /

-0.905 (-3.27%)

11/19/21 Credit Suisse
Macy's price target raised to $32 from $19 at Credit Suisse
11/19/21 Deutsche Bank
Macy's price target raised to $35 from $29 at Deutsche Bank
11/19/21 Citi
Macy's price target raised to $29 from $20 at Citi
11/18/21 Gordon Haskett
Macy's price target raised to $50 from $37 at Gordon Haskett
TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

M Macy's
$26.80 /

-0.905 (-3.27%)

M Macy's
$26.80 /

-0.905 (-3.27%)

M Macy's
$26.80 /

-0.905 (-3.27%)

TR Tootsie Roll
$32.76 /

+0.235 (+0.72%)

M Macy's
$26.80 /

-0.905 (-3.27%)

Hot Stocks
FactSet Research to replace Western Union in S&P500 on 12/20  17:30
12/03/21
12/03
17:30
12/03/21
17:30
FDS

FactSet

$466.62 /

-3.84 (-0.82%)

, WU

Western Union

$17.23 /

+0.08 (+0.47%)

 
ShowHide Related Items >><<
WU Western Union
$17.23 /

+0.08 (+0.47%)

FDS FactSet
$466.62 /

-3.84 (-0.82%)

FDS FactSet
$466.62 /

-3.84 (-0.82%)

12/01/21 RBC Capital
FactSet price target raised to $525 from $453 at RBC Capital
10/07/21 RBC Capital
FactSet price target raised to $453 from $425 at RBC Capital
09/30/21 Stifel
FactSet price target raised to $400 from $337 at Stifel
09/30/21
Fly Intel: Top five analyst upgrades
WU Western Union
$17.23 /

+0.08 (+0.47%)

11/03/21 Deutsche Bank
Western Union price target lowered to $18 from $25 at Deutsche Bank
10/20/21
Fly Intel: Top five analyst downgrades
10/20/21 BTIG
Western Union downgraded to Neutral from Buy at BTIG
10/14/21 Susquehanna
Western Union price target lowered to $23 from $26 at Susquehanna
WU Western Union
$17.23 /

+0.08 (+0.47%)

FDS FactSet
$466.62 /

-3.84 (-0.82%)

WU Western Union
$17.23 /

+0.08 (+0.47%)

WU Western Union
$17.23 /

+0.08 (+0.47%)

FDS FactSet
$466.62 /

-3.84 (-0.82%)

WU Western Union
$17.23 /

+0.08 (+0.47%)

Hot Stocks
SolarEdge to replace Hanesbrands in S&P500 on 12/20  17:29
12/03/21
12/03
17:29
12/03/21
17:29
SEDG

SolarEdge

$306.25 /

-11.29 (-3.56%)

, HBI

Hanesbrands

$16.48 /

+0.03 (+0.18%)

 
ShowHide Related Items >><<
SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

11/30/21
Fly Intel: Top five analyst downgrades
11/30/21 Morgan Stanley
SolarEdge downgraded to Equal Weight from Overweight at Morgan Stanley
11/22/21 Wells Fargo
SolarEdge initiated with an Overweight at Wells Fargo
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

11/17/21 UBS
Hanesbrands price target lowered to $20 from $23 at UBS
10/04/21 Wedbush
Wedbush sees several key tailwinds for footwear and apparel sector
10/04/21 Wedbush
Hanesbrands initiated with a Neutral at Wedbush
08/06/21 B. Riley
Hanesbrands price target raised to $24 from $22 at B. Riley
SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

SEDG SolarEdge
$306.25 /

-11.29 (-3.56%)

HBI Hanesbrands
$16.48 /

+0.03 (+0.18%)

Conference/Events
Arbe Robotics to host investor and analyst meeting » 17:29
12/03/21
12/03
17:29
12/03/21
17:29
ARBE

Arbe Robotics

$10.27 /

+ (+0.00%)

Virtual Analyst and…

Virtual Analyst and Investor Meeting to be held on December 7 at 10 am. Webcast Link

ShowHide Related Items >><<
ARBE Arbe Robotics
$10.27 /

+ (+0.00%)

ARBE Arbe Robotics
$10.27 /

+ (+0.00%)

11/02/21
Fly Intel: Top five analyst initiations
11/02/21 Wells Fargo
Arbe Robotics initiated with an Overweight at Wells Fargo
10/19/21 Cowen
Arbe Robotics initiated with an Outperform at Cowen
10/19/21 Cowen
Arbe Robotics initiated with an Outperform at Cowen
Hot Stocks
Signature Bank to replace Leggett & Platt in S&P500 on 12/20  17:28
12/03/21
12/03
17:28
12/03/21
17:28
SBNY

Signature Bank

$306.21 /

-13.78 (-4.31%)

, LEG

Leggett & Platt

$41.72 /

-0.26 (-0.62%)

 
ShowHide Related Items >><<
LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

SBNY Signature Bank
$306.21 /

-13.78 (-4.31%)

11/15/21 Raymond James
Signature Bank price target raised to $400 from $360 at Raymond James
11/12/21 Stephens
ConnectOne Bancorp named a Best Idea at Stephens
10/21/21 UBS
Signature Bank price target raised to $375 from $288 at UBS
10/20/21 Wedbush
Signature Bank price target raised to $340 from $320 at Wedbush
LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

02/10/21 Raymond James
Leggett & Platt downgraded to Outperform from Strong Buy at Raymond James
02/10/21 Raymond James
Leggett & Platt downgraded to Outperform from Strong Buy at Raymond James
SBNY Signature Bank
$306.21 /

-13.78 (-4.31%)

LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

  • 21
    Jul
  • 05
    Feb
SBNY Signature Bank
$306.21 /

-13.78 (-4.31%)

LEG Leggett & Platt
$41.72 /

-0.26 (-0.62%)

Conference/Events
Tandem Diabetes to host virtual research and development day » 17:23
12/03/21
12/03
17:23
12/03/21
17:23
TNDM

TNDM

/

+

Virtual Research and…

Virtual Research and Development Day to be held on December 6 at 1:30 pm. Webcast Link

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

11/04/21 Raymond James
Tandem Diabetes price target raised to $138 from $120 at Raymond James
11/04/21 Wells Fargo
Tandem Diabetes price target raised to $137 from $121 at Wells Fargo
11/04/21 Piper Sandler
Tandem Diabetes price target raised to $140 from $132 at Piper Sandler
10/18/21 Piper Sandler
Medtronic deal would not address 'Achilles' heel' of platform, say Piper
TNDM TNDM
/

+

TNDM TNDM
/

+

Syndicate
SAB Biotherapeutics files to sell 14.4M shares of common stock for holders  17:19
12/03/21
12/03
17:19
12/03/21
17:19
SABS

SAB Biotherapeutics

$9.94 /

-0.39 (-3.78%)

 
ShowHide Related Items >><<
SABS SAB Biotherapeutics
$9.94 /

-0.39 (-3.78%)

SABS SAB Biotherapeutics
$9.94 /

-0.39 (-3.78%)

12/02/21 Northland
SAB Biotherapeutics price target raised to $21 from $18 at Northland
11/05/21
Fly Intel: Top five analyst initiations
11/05/21 Chardan
SAB Biotherapeutics initiated with a Buy at Chardan
11/02/21
Fly Intel: Top five analyst initiations
SABS SAB Biotherapeutics
$9.94 /

-0.39 (-3.78%)

Conference/Events
Immunocore to hold a virtual event » 17:19
12/03/21
12/03
17:19
12/03/21
17:19
IMCR

Immunocore

$28.64 /

-3.56 (-11.06%)

MAGE-A4 Investor &…

MAGE-A4 Investor & Analyst Event will be held on December 6 at 8 am. Webcast Link

ShowHide Related Items >><<
IMCR Immunocore
$28.64 /

-3.56 (-11.06%)

IMCR Immunocore
$28.64 /

-3.56 (-11.06%)

11/11/21 JPMorgan
Immunocore share catalysts are 'picking up,' says JPMorgan
10/19/21 Oppenheimer
Immunocore initiated with an Outperform at Oppenheimer
03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
IMCR Immunocore
$28.64 /

-3.56 (-11.06%)

  • 05
    Feb
IMCR Immunocore
$28.64 /

-3.56 (-11.06%)

Syndicate
Muscle Maker files to sell 22.1M shares of common stock for holders  17:15
12/03/21
12/03
17:15
12/03/21
17:15
GRIL

Muscle Maker

$1.02 /

-0.05 (-4.67%)

 
ShowHide Related Items >><<
GRIL Muscle Maker
$1.02 /

-0.05 (-4.67%)

GRIL Muscle Maker
$1.02 /

-0.05 (-4.67%)

GRIL Muscle Maker
$1.02 /

-0.05 (-4.67%)

Conference/Events
F-star Therapeutics to host virtual research and development day » 17:13
12/03/21
12/03
17:13
12/03/21
17:13
FSTX

F-star Therapeutics

$4.94 /

-0.295 (-5.64%)

Virtual Research &…

Virtual Research & Development Day to be held on December 6 at 8 am. Webcast Link

ShowHide Related Items >><<
FSTX F-star Therapeutics
$4.94 /

-0.295 (-5.64%)

FSTX F-star Therapeutics
$4.94 /

-0.295 (-5.64%)

11/18/21 Ladenburg
F-star Therapeutics price target lowered to $15 from $27 at Ladenburg
11/12/21 Oppenheimer
F-star Therapeutics price target raised to $33 from $30 at Oppenheimer
07/08/21 SVB Leerink
F-star Therapeutics initiated with an Outperform at SVB Leerink
06/09/21 B. Riley
B. Riley starts F-star Therapeutics at Buy, sees 307% potential upside
FSTX F-star Therapeutics
$4.94 /

-0.295 (-5.64%)

  • 09
    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.